Your browser doesn't support javascript.
loading
Sodium-glucose co-transporter-2 inhibitors and atrial fibrillation in the cardiovascular and renal outcome trials.
Okunrintemi, Victor; Mishriky, Basem M; Powell, James R; Cummings, Doyle M.
Affiliation
  • Okunrintemi V; Department of Internal Medicine, East Carolina University, Greenville, North Carolina, USA.
  • Mishriky BM; Department of Internal Medicine, East Carolina University, Greenville, North Carolina, USA.
  • Powell JR; Department of Internal Medicine, East Carolina University, Greenville, North Carolina, USA.
  • Cummings DM; Department of Family Medicine, East Carolina University, Greenville, North Carolina, USA.
Diabetes Obes Metab ; 23(1): 276-280, 2021 01.
Article in En | MEDLINE | ID: mdl-33001548
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Cardiovascular Diseases / Symporters / Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors Type of study: Clinical_trials / Etiology_studies Limits: Humans Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2021 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Cardiovascular Diseases / Symporters / Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors Type of study: Clinical_trials / Etiology_studies Limits: Humans Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2021 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido